Table 2 Serum and urinary levels of interleukins at baseline

From: High urinary interleukin-2 in late post-transplant period portends a risk of decline in kidney allograft function: a preliminary study

Interleukins level	Patient groups
	eGFR at baseline			eGFR decline by 25% at 2 years
	Normal eGFR, ≥ 60 mL/min/1.73 m² (N = 7)	Low eGFR, < 60 mL/min/1.73 m² (N = 23)	p	No (N = 23)	Yes (N = 7)	p
IL-8 (pg/mL)	3.00 (1.16–3.87)	3.10 (2.28–5.10)	0.501	3.00 (2.19–3.78)	3.87 (2.30–6.85)	0.360
IL-10 (pg/mL)	2.24 (1.49–3.33)	3.53 (2.24–4.48)	0.061	3.30 (2.24–4.01)	3.87 (1.29–4.55)	0.962
IL-2 (pg/mL)	0.20 (0.16–3.19)	0.20 (0.18–2.34)	0.924	0.64 (0.19–3.19)	0.18 (0.18–0.20)	0.107
IL-8/Cr (pg/mL/mmol/L)	0.21 (0.10–0.39)	0.60 (0.31–2.29)	0.077	0.38 (0.10–0.89)	1.18 (0.21–3.31)	0.190
IL-10/Cr (pg/mL/mmol/L)	0.08 (0.05–0.09)	0.10 (0.07–0.22)	0.118	0.09 (0.07–0.21)	0.08 (0.05–0.17)	0.501
IL-2/Cr (pg/mL/mmol/L)	0.15 (0.06–0.22)	0.25 (0.14–0.74)	0.048	0.20 (0.13–0.36)	0.56 (0.13–2.47)	0.159

IL-2, interleukin 2; IL-8, interleukin 8; IL-10, interleukin 10; Cr, creatinine

Back to article page